申请人:Darwin Discovery Limited
公开号:US05925636A1
公开(公告)日:1999-07-20
Compounds having the formula (i), ##STR1## wherein the groups R.sub.1, R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are defined herein. The compounds of the present invention can be utilized to treat disease states capable of being modulated by inhibition of proteins which mediate cellular activity, such as tumor necrosis factor (TNF) and/or phosphodiesterase IV (PDE IV).
具有公式(i)的化合物,其中,R.sub.1,R.sub.2,R.sub.3,R.sub.4和R.sub.5基团的定义如下:##STR1## 本发明的化合物可用于治疗能够通过抑制介导细胞活性的蛋白质,如肿瘤坏死因子(TNF)和/或磷酸二酯酶IV(PDE IV)调节的疾病状态。